Proton Therapy Pediatric denied due to quantity / dose limits by Aetna?
Quantity-limit denials usually flip when the appeal documents the clinically appropriate dose for the patient's weight, kidney function, or escalation schedule, citing the FDA label or specialty-society guideline.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Aetna typically requires
Aetna's specific coverage criteria for proton therapy pediatric are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Aetna angle on Proton Therapy Pediatric
## Why Aetna Applies Quantity Limits to Pediatric Proton Therapy
For radiation therapy, a quantity-limit denial typically means that Aetna's reviewer determined that the number of treatment fractions, the total course duration, or the overall treatment volume requested exceeds what the plan's clinical policy considers appropriate for the submitted diagnosis. In pediatric proton therapy, quantity-limit denials may arise when the authorized fraction count does not match the prescribed course, when re-irradiation is requested, or when a treatment course is extended due to clinical factors that were not communicated at the time of authorization.
## Why This Denial Is Appealable
Radiation fractionation is an individualized clinical decision driven by tumor histology, location, patient age, prior treatment history, and the prescribing radiation oncologist's clinical judgment. A plan's default quantity limit is a utilization benchmark, not a clinical prescription. When the prescribed course deviates from that benchmark for medically documented reasons — re-irradiation, boost fractions, anatomical complexity, or pediatric-specific dosing considerations — those reasons constitute the basis for overturning the quantity-limit denial. The appeal must document the specific clinical rationale for each fraction or treatment unit beyond the plan's limit.
## Federal Appeal Framework
- Internal appeal: File within 180 days of the denial. Request the specific quantity limit applied and the policy provision that sets it.
- External review (ACA §2719): After internal denial, an IRO reviews whether the quantity limitation was appropriately applied to this patient's clinical situation.
- ERISA §503: The plan must disclose the clinical basis for the limit and permit response to any new evidence used in the appeal.
- Expedited review: Available if treatment is ongoing and the quantity-limit denial interrupts the course of care — document the clinical urgency.
- External review window: Initiate within four months of the final internal denial.
## Documentation to Gather
- Treatment plan and prescription: The full radiation prescription with the treating physician's rationale for the prescribed fractionation schedule.
- Radiation oncologist's medical-necessity letter: Specific explanation of why the prescribed number of fractions is medically necessary for this patient, addressing any deviation from the plan's standard limit.
- Pediatric-specific clinical factors: Chart documentation of any pediatric-specific considerations that affect fractionation — developmental factors, organ tolerance, boost requirements.
- Prior treatment history: If re-irradiation is involved, complete documentation of prior radiation fields, doses received, interval since prior treatment, and clinical rationale for re-treatment.
- Diagnosis and staging: Full oncologic workup supporting the treatment plan.
## Criteria-Mapping Structure
Obtain the exact quantity limit Aetna applied from the denial letter or from Aetna's clinical policy. State that limit explicitly in the appeal. Then, for each fraction or treatment unit beyond the limit, provide the specific clinical reason documented in the chart — cite the document, author, and date. If the plan's policy contains exceptions to the quantity limit, identify every applicable exception and document how this patient's case meets it. A precise, fraction-by-fraction clinical justification is more persuasive than a general argument about treatment necessity.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →